← back to search

Elsken van der Wall

Utrecht University · NL
Area of research
Cancer Research · Oncology
Research interest
Research focused on Breast cancer and Cancer research, with related work in Wnt signaling pathway, CINAHL, Cancer. Notable publications include 'Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study', 'Targeting DDX3 with a small molecule inhibitor for lung cancer therapy', and 'The Validity of Using Analogue Patients in Practitioner–Patient Communication Research: Systematic Review and Meta-Analysis'.
h-index
citations
2,495
works
45
NIH funding
primary concept
email

Recent publications

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial
Journal of Clinical Oncology 2025cited by 7position: middledoi
Impact of exercise on sexual health, body image, and therapy‐related symptoms in women with metastatic breast cancer: The randomized controlled <scp>PREFERABLE</scp>‐<scp>EFFECT</scp> trial
International Journal of Cancer 2025cited by 5position: middledoi
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial
Nature Medicine 2024cited by 59position: middledoi
Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial
Nature Cancer 2024cited by 25position: middledoi
Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
npj Breast Cancer 2024cited by 15position: middledoi
Cost-utility analysis of a supervised exercise program for patients with metastatic breast cancer in the PREFERABLE-EFFECT randomized controlled trial (RCT).
Journal of Clinical Oncology 2024cited by 3position: middledoi
Abstract GS02-10: Effects of a structured and individualized exercise program on fatigue and health-related quality of life in patients with metastatic breast cancer: the multinational randomized controlled PREFERABLE-EFFECT study
Cancer Research 2024cited by 2position: middledoi
Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)
Breast Cancer Research 2022cited by 103position: middledoi
MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis
npj Breast Cancer 2022cited by 64position: middledoi
The microRNA Lifecycle in Health and Cancer
Cancers 2022cited by 40position: middledoi
Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life: the EFFECT study
Trials 2022cited by 36position: middledoi
Effect of physical exercise on the hippocampus and global grey matter volume in breast cancer patients: A randomized controlled trial (PAM study)
NeuroImage Clinical 2022cited by 16position: middledoi
Patients' preferred and perceived level of involvement in decision making for cancer treatment: A systematic review
Psycho-Oncology 2021cited by 100position: middledoi
Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile
Breast Cancer Research and Treatment 2021cited by 43position: middledoi
Mind your words: Oncologists' communication that potentially harms patients with advanced cancer: A survey on patient perspectives
Cancer 2021cited by 40position: middledoi
Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer
Medicine & Science in Sports & Exercise 2021cited by 35position: middledoi
Addressing challenges in information-provision: a qualitative study among oncologists and women with advanced breast cancer
BMC Palliative Care 2021cited by 19position: middledoi
Nipple Aspirate Fluid at a Glance
Cancers 2021cited by 15position: middledoi
Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in <i>de novo</i> stage IV breast cancer patients: study protocol of the i-GO study
BMJ Open 2020cited by 29position: middledoi
Lessons Learned from Setting Up a Prospective, Longitudinal, Multicenter Study with Women at High Risk for Breast Cancer
Cancer Epidemiology Biomarkers & Prevention 2020cited by 20position: lastdoi
Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways
Acta Physiologica 2019cited by 122position: middledoi
Tumor Response After Neoadjuvant Magnetic Resonance Guided Single Ablative Dose Partial Breast Irradiation
International Journal of Radiation Oncology*Biology*Physics 2019cited by 74position: middledoi
Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: The PACT study
PLoS ONE 2019cited by 64position: middledoi
Tamoxifen and pregnancy: an absolute contraindication?
Breast Cancer Research and Treatment 2019cited by 64position: middledoi
The molecular genetic make-up of male breast cancer
Endocrine Related Cancer 2019cited by 50position: middledoi
The Use of Expectancy and Empathy When Communicating With Patients With Advanced Breast Cancer; an Observational Study of Clinician–Patient Consultations
Frontiers in Psychiatry 2019cited by 33position: middledoi
Four-year effects of exercise on fatigue and physical activity in patients with cancer
BMC Medicine 2018cited by 85position: middledoi
Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis
eLife 2018cited by 53position: middledoi
Cardio-oncology: an overview on outpatient management and future developments
Netherlands Heart Journal 2018cited by 42position: middledoi
Author response: Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis
2018cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

P. J. van Diest · Altrecht GGZ16 papers (2012–2024)Anne M. May · Utrecht University8 papers (2017–2024)Patrick W.B. Derksen · Utrecht University6 papers (2012–2018)Cathy B. Moelans · Utrecht University6 papers (2018–2022)Jeroen F. Vermeulen · Utrecht University5 papers (2012–2018)Petra van der Groep · Utrecht University5 papers (2012–2019)Sabrina Oliveira · Utrecht University4 papers (2013–2016)Anouk E. Hiensch · Utrecht University4 papers (2018–2024)Miranda J. Velthuis · Pennsylvania State University4 papers (2017–2021)Willem P.Th.M. Mali · University Hospital Heidelberg4 papers (2013–2016)Aram S. A. van Brussel · Utrecht University3 papers (2013–2016)Arthur L.L. Adams · Utrecht University3 papers (2013–2016) · 3 papers (2019–2021)Paul M.P. van Bergen en Henegouwen · Utrecht University3 papers (2013–2016)Martijn M. Stuiver · Utrecht University3 papers (2021–2024)Natalie D. ter Hoeve · Utrecht University3 papers (2016–2024)Anneke L. Francke · Amsterdam Neuroscience3 papers (2019–2021)Arjen J. Witkamp · Utrecht University3 papers (2016–2020)Nicole Plum · Utrecht University3 papers (2012–2021)Martina E. Schmidt · German Cancer Research Center3 papers (2017–2024)